Company intelligence / Profile preview
DynamiCure Biotech
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
DynamiCure Biotech is a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapies for cancer and autoimmune diseases. The company leverages its proprietary D-Leap platform to identify and target novel biological pathways, with a particular emphasis on the CD24 and CXCL13/CXCR5 axes. Its lead candidate, DCB-001, is a first-in-class monoclonal antibody targeting CD24 currently undergoing Phase 1 clinical trials for advanced solid tumors. DynamiCure operates with a global footprint, maintaining research and development facilities in both the United States and China to accelerate the delivery of transformative medicines to patients worldwide.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodyAntibodyBispecific monoclonal antibody
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on DynamiCure Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DynamiCure Biotech.